A detailed history of State Of Wyoming transactions in Myriad Genetics Inc stock. As of the latest transaction made, State Of Wyoming holds 3,895 shares of MYGN stock, worth $52,582. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,895
Holding current value
$52,582
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $93,363 - $111,397
3,895 New
3,895 $106,000
Q1 2023

May 12, 2023

BUY
$15.26 - $23.75 $24,675 - $38,403
1,617 New
1,617 $37,000
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $13,225 - $20,807
804 New
804 $15,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.09B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.